Regeneron's Arcalyst Fails to Win Panel Backing for Gout - BusinessWeek

French Tribune

Regeneron's Arcalyst Fails to Win Panel Backing for Gout BusinessWeek By Anna Edney on May 08, 2012 Regeneron Pharmaceuticals Inc. (REGN) (REGN) failed to win the backing of advisers to the US Food and Drug Administration to expand the use of the autoinflammatory drug Arcalyst to include patients undergoing gout ... FDA advisers rebuff Regeneron gout drugChicago Tribune FDA Panel Votes Against Rilonacept For Gout Flare PreventionMedscape Regeneron Dips on Safety Concern Over Gout Treatment [UPDATE]Minyanville.com HealthNews -MarketWatch (press release) -pharmabiz.com all 59 news articles »

FDA: Regeneron Drug Offers 'Small' Benefit In Gout - Wall Street Journal

FDA: Regeneron Drug Offers 'Small' Benefit In Gout Wall Street Journal By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--The US Food and Drug Administration said that the treatment effect from a proposed Regeneron Pharmaceuticals Inc. (REGN) treatment for gout was "small," and the agency raised ... FDA staff question side effects of Regeneron gout drugChicago Tribune Regeneron Dips on Safety Concern Over Gout TreatmentMinyanville.com FDA Panel To Find If Regeneron Gout Drug's Risks Too HighLaw360 (subscription) all 27 news articles »

Arcalyst: Gout Drug Is Effective, But Side Effects Questioned By FDA - Huffington Post

Arcalyst: Gout Drug Is Effective, But Side Effects Questioned By FDA Huffington Post By Anna Yukhananov WASHINGTON, May 4 (Reuters) - US drug reviewers said Regeneron Pharmaceuticals Inc's drug to prevent gout flares worked, but questioned its side effects and whether it did enough to help patients. The Food and Drug Administration ... Regeneron Drug's Benefit May Not Outweigh Risk, FDA SaysBusinessWeek all 3 news articles »

Regeneron: FDA panel says no to Arcalyst for gout - CBS News

French Tribune

Regeneron: FDA panel says no to Arcalyst for gout CBS News TARRYTOWN, NY — Regeneron Pharmaceuticals Inc. said Tuesday that a Food and Drug Administration panel has recommended its drug Arcalyst not be approved as a treatment for gout. Regeneron has asked the FDA to approve the use of Arcalyst for the ... FDA Advisory Panel Rejects Clearance of Arcalyst for GoutFrench Tribune all 6 news articles »